AlphaMaven AlphaMaven

Private-Equity Speed Runner LifeStance Targets A Profound Void - Investor's Business Daily

Reported by Investors
Nov 13, 2026· 1 min read
Save Post LinkedIn Email
Key Takeaways
  • • LifeStance Health (LFST) stock has roughly doubled this year, outpacing telehealth peers Teladoc Health (TDOC), Hims & Hers Health (HIMS) and Doximity (DOCS), according to Investor's Business Daily.
  • • The behavioral health services company was built rollup-style through about 100 acquisitions and private-equity backing.
  • • LifeStance is now delivering double-digit revenue growth and clinician additions, with some organic growth, per the report.
Summary
LifeStance Health (LFST) shares have been on a strong run this year, roughly doubling in value and outperforming several telehealth and digital health peers, including Teladoc Health (TDOC), Hims & Hers Health (HIMS) and Doximity (DOCS), according to Investor's Business Daily.

The behavioral health services provider was assembled largely through a rollup strategy, executing about 100 acquisitions with private-equity backing. That model has supported its expansion into a larger national network of mental health clinicians.

According to the report, the company is now delivering double-digit revenue growth and clinician additions, with some of that growth coming organically rather than solely from acquisitions. The source article's summary is brief, so further details on financial metrics, valuation, and forward guidance are not available from this coverage.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Investors Private-Equity Speed Runner LifeStance Targets A Profound Void - Investor's Business Daily